Analyst Ranking
Bottom 9%
#5050 out of 5510 analysts
Average Return
-6.23%
Win Rate
38%8 out of 21
Risk vs Reward
Poor
Good

William Woods's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifemd IncLFMD
+38.00%$7.71$10.64
2024-05-21 -
2025-05-20
Strong Buy
Immunic IncIMUX
+34.05%$9.18$12.30
2025-05-23 -
2026-05-21
Strong Buy
Koru Medical Systems IncKRMD
+23.29%$2.19$2.70
2024-03-14 -
2025-03-13
Strong Buy
Aardvark Therapeutics IncAARD
+21.44%$4.57$5.55
2026-05-15 -
2026-09-14
Strong Buy
Immunic IncIMUX
+17.71%$9.43$11.10
2025-04-16 -
2026-04-15
Strong Buy

William Woods Analyst Color

Get additional color on William Woods's coverage of popular stocks

William Woods's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alpha Cognition IncACOG
1Strong Buy$21.00+141.10%Initiates Coverage On
a month ago
Lifemd IncLFMD
4Strong Buy$8.00+132.56%Maintains
a month ago
Tg Therapeutics IncTGTX
1Strong Buy$86.00+59.26%Maintains
2 months ago
Agomab Therapeutics NvAGMB
1Strong Buy$34.00+176.87%Initiates Coverage On
2 months ago
Immunic IncIMUX
4Strong Buy$27.00+140.43%Maintains
4 months ago
Aardvark Therapeutics IncAARD
1Strong Buy$7.00+26.13%Maintains
4 months ago
Equillium IncEQ
1Strong Buy$6.00+186.40%Initiates Coverage On
5 months ago
Koru Medical Systems IncKRMD
2Strong Buy$8.00+154.78%Maintains
6 months ago
Altimmune IncALT
1Strong Buy$13.00+293.94%Maintains
6 months ago
Palisade Bio IncPALI
1Strong Buy$7.00+241.46%Initiates Coverage On
8 months ago
Madrigal Pharmaceuticals IncMDGL
1Strong Buy$670.00+24.06%Maintains
9 months ago
Okyo Pharma LtdOKYO
1Strong Buy$5.00+257.14%Initiates Coverage On
9 months ago
Cognition Therapeutics IncCGTX
1Strong Buy$3.00+197.03%Reiterates
10 months ago
Veru IncVERU
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Just Eat Takeawaycom NvJTKWY
1HoldN/AN/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.